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Background: Sclerosing encapsulating peritonitis (SEP) is a rare cause of small-bowel obstruction. The optimal
treatment for this condition remains controversial.
Methods: In this study, we performed a retrospective analysis of the data of 44 patients who underwent surgery
for SEP between December 2001 and 2008 at our hospital. The long-term follow-up data of the patients were
assessed for the recurrence of adhesive small-bowel obstruction (ASBO), and patient survival was assessed to
evaluate the efficiency of tube splinting in the prevention of postoperative ASBO.
Results: Of the 44 patients who underwent surgery for SEP, 33 underwent simple enterolysis along with tube
splinting, while the remaining underwent only simple enterolysis. The median follow-up period was 79.4 ± 24.8 months
(range: 8–123 months). The rate of complications was 9.1% and 6.1% in the simple enterolysis group and tube-splinting
group, respectively (P = 0.73). The recurrence rate of ASBO was lower in the tube-splinting group (6.7%) than in the
simple enterolysis group (40%) (P = 0.02).
Conclusion: Our findings indicate that tube splinting may be more useful than simple enterolysis alone in preventing
the recurrence of ASBO in patients with SEP.
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Sclerosing encapsulating peritonitis (SEP), a rare cause
of intestinal obstruction, is characterized by the forma-
tion of a fibrotic membrane that either partially or com-
pletely encases the small bowel [1]. The etiology and
pathogenesis of SEP are yet to be elucidated. The salient
clinical features of SEP are recurrent episodes of acute
or subacute small-bowel obstruction (SBO); weight loss;
nausea; anorexia; and, occasionally, a palpable abdominal
mass [2]. SEP is difficult to diagnose and is often de-
tected during surgery for the correction of SBO. The in-
cidence of postoperative adhesive SBO (ASBO) has been
reported to be 14.3–29% [1,3].
SEP is a rare disease and most studies on this condi-
tion are based on a small number of patients and short* Correspondence: liningrigs@vip.sina.com
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unless otherwise stated.follow-up periods [4-7]. The optimal treatment strategy
for SEP remains controversial. Although there is a general
consensus on the need for surgery for the treatment of the
SEP, various surgical approaches are employed, including
subtotal excision of the membrane, enterolysis, small-
bowel resection, and exploratory laparotomy, followed by
postoperative medical treatment [3,8,9].
Long intestinal tube splinting, which was first de-
scribed by White [10] and popularized later by Baker
[11], has been proven to be efficient in mitigating the
disease recurrence rate in patients with ASBO [12,13].
However, no study has thus far examined the efficiency
of this procedure in patients with ASBO due to SEP.
This study is aimed at determining whether tube splint-
ing in patients with SEP is more effective than simple
enterolysis alone in preventing the recurrence of ASBO
over the long term.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Intraoperative photograph of a patient with SEP
(membrane encapsulates the entire intestine).
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were followed up for a mean of 79.4 months. To our
knowledge, this study has the largest sample size and
longest follow-up duration recorded thus far among in-
vestigations on patients with SEP.
Methods
Study protocol
The study was designed as a retrospective investigation
of the long-term follow-up data of all patients who
had undergone surgery for the correction of SBO due
to SEP at the Department of General Surgery, Jinling
Hospital, Medicine School of Nanjing University, China,
between December 2001 and 2008. The study protocol
was approved by the Ethics Committee at Jinling Hos-
pital and was in compliance with the Chinese national
legal regulations.
Patients
The diagnosis of SEP was confirmed on the basis of in-
traoperative findings, as described previously [1]. The
patients were classified into two groups depending on
whether they underwent simple enterolysis alone (simple
enterolysis group; n = 11) or simple enterolysis along
with long intestinal tube splinting (tube splinting group;
n = 33). The diagnosis of postoperative ASBO, as per the
medical records, was defined by hospital admission with
abdominal pain, distention, vomiting, and obstipation
(failure to pass gas and feces) along with radiological evi-
dence of intestinal obstruction. The demographic char-
acteristics and medical records of the 44 patients were
carefully reviewed for the assessment of postoperative
morbidity and hospital mortality. All patients were
followed up by telephonic interviews to evaluate the re-
currence rate of ASBO. The final follow-up interviews
were held on December 30, 2012. Survival was calcu-
lated as the duration between the date of the operation
for ASBO to the date of recurrence, subsequent abdom-
inal operation, death, or the end of the study.
Statistical analysis
The demographic and baseline characteristics of the pa-
tients were presented in terms of mean ± standard devi-
ation. The recurrence rate of ASBO was determined by
survival analysis methods. The cumulative survival rates
were calculated by the Kaplan–Meier method, and the
intergroup differences were assessed using the log-rank
test. Relative risks were expressed as hazard ratios (HRs)
with a 95% confidence interval (CI). The complication
rates in the two groups were compared by the chi-
square test. Statistical analysis was performed using
SPSS 18.0 for Windows (SPSS Inc., Chicago). A P value
of <0.05 was considered statistically significant.Results
Between December 2001 and 2008, 44 patients (men: 36;
women: 8; median age: 44 ± 11.5 years; range: 19–70
years) underwent surgical correction of ASBO due to
SEP. Thirty of these patients had a history of previous
surgery, including nine who had undergone exploratory
laparotomy for SEP. None of the patients had received
peritoneal dialysis.
Intraoperative findings
On laparotomy, 31 of the 44 patients were found to have
membrane encapsulation extending throughout the en-
tire intestine (Figure 1), while 13 had encapsulation of
only small parts of the intestine. All patients had exten-
sive adhesions between different bowel segments and be-
tween the membrane and intestine, with 12 patients
exhibiting multiple matted inter-bowel adhesions. On
laparotomy, all patients received total resection of mem-
brane and lysis of adhesions. Six patients underwent in-
advertent enterectomy. In all the patients, histologic
examination of the membrane showed proliferation of
fibrocytes and collagen fiber with nonspecific inflamma-
tory reaction.
Long intestinal tube splinting
The decision of whether tube splinting should be per-
formed for the patients was made on the basis of the
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was effective in preventing the recurrence of ASBO.
Therefore, some patients (n = 33) underwent tube splint-
ing, while others did not. Two, three, or four 16-F tubes
of length 150 cm were used as necessary and sutured to-
gether using 2/0 silk. Small side holes were cut at 15-cm
intervals along the tubes. Appendicectomy was per-
formed, and the tube was introduced into the base of
the appendix (n = 26) or the stump of the terminal ileal
anastomosis (n = 1) and then advanced upwards into the
duodenojejunal flexure (Figure 2). In the remaining 6 pa-
tients who had previously undergone appendectomy, the
tubes were introduced via cecostomy. The tubes were
left in situ for a median duration of 11.5 ± 2.4 days, after
which the tubes were removed.
Mortality and morbidity
No case of postoperative death was recorded in this cohort.
Three patients developed early postoperative inflammatory
intestinal obstruction, which was resolved by expectant
treatment. The overall rate of complications was 6.8%
(Table 1), and the rates in the simple enterolysis group
(9.1%) and the tube splinting group (6.1%) did not show
any significant difference (P = 0.73).
Follow up and postoperative ASBO
Four patients (1 in the simple enterolysis group and 3 in
tube splinting group) were lost to follow up. The overall
mean follow-up duration for the remaining 40 patients
was 79.4 ± 24.8 months (range: 8 to 123 months), while
that in the simple enterolysis group and tube splinting
group was 65.5 ± 32.8 months (range: 8–104 months) and
84 ± 20.2 months (range: 50–123 months), respectively.Figure 2 Long intestinal tube introduced through the base of the appSix patients (15%) had 17 episodes of postoperative
ASBO: 15 were managed conservatively and 2, surgically
(Table 1). One patient required 1 hospital admission for
postoperative ASBO, 1 required 2 admissions, 3 required
3, and 1 required 5. The cumulative incidence of ASBO
was 10% at 1 year, 12.5% at 2 years, and 15% at 3 years
and at the end of study. The number of postoperative
ASBO episodes was greater in the simple enterolysis
group (4/10; 40%) than in the tube splinting group (2/30;
6.7%) [P = 0.02; HR = 0.134 (0.024–0.773)] (Figure 3).
Discussion
SEP is a rare clinical condition of unknown etiology. It is
believed to be caused by recurrent low-grade or subclin-
ical peritonitis, which does not manifest with any signifi-
cant abdominal signs and eventually leads to sclerosis
and membrane formation with subsequent formation of
a cocoon [14]. Since the condition is not associated with
any specific set of symptoms, most cases are diagnosed
incidentally during laparotomy.
Due to the lack of long-term studies on a large num-
ber of patients with SEP, the optimal treatment for this
condition remains debatable. Most of the pertinent stud-
ies published thus far have been conducted on a small
number of patients (1–9 patients) and over a short
follow-up period (10–25 months) [1,5-8,15,16]. Celicout
et al. [3] reported a case series of 32 patients who under-
went four types of procedures, namely, membrane resec-
tion (n = 5), enterolysis with partial excision of the
membrane (n = 12), intestinal resection (n = 7), and only
exploratory laparotomy (n = 8). The recurrence rate of
ASBO in their study was 29% over a mean follow-up
period of 49.5 months. The current study investigatedendix after appendicectomy.
Table 1 Postoperative complication and ASBO in two
groups
n Complication (%) Follow-up (n) ASBO (n) (%)
Enterolysis
group




33 2(6.1%) 30 2(1 re-operation)
(6.7%)
Total 44 3(6.8%) 40 6(2 re-operation)
(15%)
ASBO: adhesive small bowel obstruction.
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SEP. Since all the enrolled patients had extensive adhe-
sions between bowel segments and between the mem-
brane and intestine, total resection of the membrane
and adhesiolysis was performed in all the patients.
In addition, 33 patients received long intestinal tube
splinting. At the end of a mean follow-up period of
79.4 months, the recurrence rates of ASBO in the study
population and in the tube splinting group were 15%
and 6.7%, respectively. Compared to previous studies on
the recurrence rates of ASBO due to SEP managed with
simple enterolysis [1,3,5-8,15,16], ours indicated a lower
rate in a larger cohort of patients managed with tube
splinting, over a longer follow-up period.
The histological characteristics of the membranous
tissue are proliferation of fibroconnective tissue and
non-specific chronic inflammatory reaction [15]. ThisFigure 3 Cumulative survival rates after surgery in patients who did osuggests that patients with SEP are prone to develop fi-
brin deposition. This, in turn, implies that postoperative
adhesions in SEP patients would be inevitable since ex-
cessive deposition of fibrin leads to the formation of ad-
hesions [17]. The strategy of long intestinal tube
splinting is based on acknowledging the possibility of
the formation of adhesions and fixing the bowel so as to
ensure a favorable lie and thereby prevent the recurrence
of ASBO. In patients having ASBO with multiple matted
adhesions, long intestinal tube splinting has been shown
to decrease the recurrence rate of ASBO [18]. Our study
clearly showed that the recurrence rate of ASBO in the
tube splinting group was lower than that in the simple
adhesiolysis group (6.7% vs. 40%, P = 0.02).
Mortality due to ASBO has been reported to be
0–71% [3,16,19,20]. There were no deaths in our case
series. The postoperative complications recorded in
the previous studies were enterocutaneous fistula and
early postoperative intestinal obstruction, at a rate of
8.7–66.7% [3,7,16]. These rates are greater than those
in our study, wherein the overall complication rate
was 6.8%, without any significant intergroup differences
(P = 0.73). We believe that correct preoperative diagnosis
and careful separation of the adhesions are important to
decrease the rate of complications. When the diagnosis
is established before the surgery, the surgeon can be
well prepared for the operation and take special precau-
tion to avoid intestinal injury when the abdominal cavityr did not undergo tube splinting (Kaplan–Meier analysis).
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to confirm the diagnosis, and the characteristic findings in
all cases are dilation of the small bowel in the middle of
the abdomen and encasement of the bowels by a thick
membrane sac [21].
The limitations of the study are that it is retrospective
in nature and that it was conducted at a single center.
These drawbacks can be overcome by further investiga-
tions on a wider population base.Conclusion
In conclusion, this was the largest study with the longest
follow-up duration published thus far on patients with
ASBO due to SEP. This retrospective study revealed that
tube splinting may be more useful than simple enteroly-
sis alone in preventing the recurrence of ASBO in pa-
tients with SEP. The rate of postoperative complications
and recurrence of ASBO in this study were the lower
than those reported thus far.
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